Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04940052 |
| Title | Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | TUR | CAN | BRA | ARG |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Northwestern University Med School | Chicago | Illinois | 60611 | United States | Details | |
| Novartis Investigative Site | Caba | Buenos Aires | C1417DTB | Argentina | Details | |
| Novartis Investigative Site | Rio De Janiero | RJ | 20231-050 | Brazil | Details | |
| Novartis Investigative Site | Blumenau | Santa Catarina | 89015-200 | Brazil | Details | |
| Novartis Investigative Site | Sao Paulo | SP | 01246-000 | Brazil | Details | |
| Novartis Investigative Site | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
| Novartis Investigative Site | London | Ontario | N6A 5W9 | Canada | Details | |
| Novartis Investigative Site | Fuzhou | Fujian | 350014 | China | Details | |
| Novartis Investigative Site | Zhengzhou | Henan | 450008 | China | Details | |
| Novartis Investigative Site | Wuhan | Hubei | 430022 | China | Details | |
| Novartis Investigative Site | Changsha | Hunan | 410013 | China | Details | |
| Novartis Investigative Site | Nanjing | Jiangsu | 210006 | China | Details | |
| Novartis Investigative Site | Nanjing | Jiangsu | 210009 | China | Details | |
| Novartis Investigative Site | Xuzhou | Jiangsu | 221003 | China | Details | |
| Novartis Investigative Site | Changchun | Jilin | 130033 | China | Details | |
| Novartis Investigative Site | Chengdu | Sichuan | 610041 | China | Details | |
| Novartis Investigative Site | Tianjin | Tianjin | 300121 | China | Details | |
| Novartis Investigative Site | Beijing | 100036 | China | Details | ||
| Novartis Investigative Site | Beijing | 100730 | China | Details | ||
| Novartis Investigative Site | Guangzhou | 510060 | China | Details | ||
| Novartis Investigative Site | Shanghai | 200233 | China | Details | ||
| Novartis Investigative Site | Tianjin | 300052 | China | Details | ||
| Novartis Investigative Site | Tianjin | 300480 | China | Details | ||
| Novartis Investigative Site | Hisar | Haryana | 125005 | India | Details | |
| Novartis Investigative Site | Chennai | 600 020 | India | Details | ||
| Novartis Investigative Site | New Delhi | 110029 | India | Details | ||
| Novartis Investigative Site | Seoul | Seocho Gu | 06591 | Korea, Republic of | Details | |
| Novartis Investigative Site | Seoul | 03080 | Korea, Republic of | Details | ||
| Novartis Investigative Site | Seoul | 05505 | Korea, Republic of | Details | ||
| Novartis Investigative Site | Seoul | 06351 | Korea, Republic of | Details | ||
| Novartis Investigative Site | Kuching | Sarawak | 93586 | Malaysia | Details | |
| Novartis Investigative Site | Kuala Lumpur | 59100 | Malaysia | Details | ||
| Novartis Investigative Site | Pulau Pinang | 10990 | Malaysia | Details | ||
| Novartis Investigative Site | Tainan | 70403 | Taiwan | Details | ||
| Novartis Investigative Site | Taipei | 10002 | Taiwan | Details | ||
| Novartis Investigative Site | Istanbul | TUR | 34098 | Turkey | Details | |
| Novartis Investigative Site | Adana | 01250 | Turkey | Details | ||
| Novartis Investigative Site | Ankara | 06500 | Turkey | Details | ||
| Novartis Investigative Site | Edirne | 22030 | Turkey | Details | ||
| Novartis Investigative Site | Hanoi | 100000 | Vietnam | Details |
CKB CORE allows for only a limited number of monthly page views for un-registered users. However, registration is free and allows for unlimited browsing of the CKB CORE content.
You have reached the monthly page view limit. For continued free access to CKB CORE, please register below: